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INTRODUCTION
Employing ELISAs as a means of examining archaeological 
materials for evidence of protozoan parasites has become in-
creasingly more routine among archaeoparasitological re-
searchers [1-15]. Much of the existing work has focused on the 
recovery of protozoan parasite antigens from latrine sediments 
[4,9-11,13,14]. In addition to sediments, Gonçalves et al. [4] 
examined 22 coprolites from Brazil, Chile, and Sudan using 
an ELISA kit for detecting Entamoeba histolytica coproantigens 
and did not find any positive samples. Allison et al. [1] used 
ELISAs to test coprolites from the intestinal tracts of mummies 
for Cryptosporidium sp. and Giardia sp. antigens. Another study 
tested coprolites for Giardia duodenalis antigens and found 
4/84 to be positive [2]. Recently, Morrow and Reinhard [15] 
recovered Cryptosporidium parvum coproantigens from 66/90 
coprolites excavated from a cave in Durango, Mexico.
Quids, which are expectorated masses of human-masticated 
plant fibers, are desiccated artifacts commonly found at New 
World archaeological sites. These artifacts are frequently over-
looked despite their potential importance in the interpretation 
of ancient diets and diseases. Quid analyses have involved 
plant fiber identification, dental impressions, and phytolith 
recovery [16-19]. Such studies have examined the role of quid 
chewing in the development of dental wear among archaeo-
logical populations. Hammerl and colleagues [19] were also 
able to use dental impressions of quids to recover demograph-
ic (age) data. The quids were all phytolith-rich and most were 
derived from Agave plant fibers, although maize leaves and 
husks were also identified among some of the quids [19]. The 
phytoliths of Agave are quite abrasive, capable of inflicting 
damage to substances as resilient as tooth enamel [18]. Be-
cause these phytoliths, along with those of other dietary abra-
sives recovered from coprolites and quids [18,20], are able to 
cause dental wear, it is likely that they may have also created 
microlacerations within the soft tissues of the mouth. Such 
microlacerations would have caused minor bleeding, releasing 
a flood of biomolecules into the mouth as a quid bolus was 
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Abstract: In the present study, quids from La Cueva de los Muertos Chiquitos (CMC) were subjected to ELISA tests for 2 
protozoan parasites, Toxoplasma gondii (n=45) and Trypanosoma cruzi (n=43). The people who occupied CMC, the 
Loma San Gabriel, lived throughout much of present-day Durango and Zacatecas in Mexico. The known pathoecology of 
these people puts them into at-risk categories for the transmission of T. gondii and T. cruzi. Human antibodies created in 
response to these 2 parasites can be detected in modern saliva using ELISA kits intended for use with human serum. For 
these reasons, quids were reconstituted and subjected to ELISA testing. All test wells yielded negative results. These re-
sults could be a factor of improper methods because there is no precedence for this work in the existing literature. The 
results could equally be a simple matter of parasite absence among those people who occupied CMC. A final consider-
ation is the taphonomy of human antibodies and whether or not ELISA is a sufficient method for recovering antibodies 
from archaeological contexts. An additional ELISA test targeting secretory IgA (sIgA) was conducted to further examine 
the failure to detect parasite-induced antibodies from quids. Herein, the methods used for quid preparation and ELISA 
procedures are described so that they can be further developed by future researchers. The results are discussed in light 
of the potential future of quid analysis.
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formed. This creates the potential for such biomolecules to be-
come integrated within the quid bolus prior to expectoration. 
Salivary antibodies, such as secretory IgA (sIgA), would have 
become similarly integrated into the quid bolus.
A few studies have employed ELISA tests for the purposes of 
diagnosing parasitic infections using modern saliva [22,23]. 
The recovery of species-specific parasite-induced antibodies 
from human saliva in modern contexts begs the question: Can 
these antibodies be recovered from archaeological materials 
saturated with desiccated human saliva? To answer this ques-
tion, one first must contemplate the preservation potential of 
such antibodies. While parasite-specific coproantigens have 
been demonstrated to preserve within archaeological materials 
like coprolites and latrine sediments, the recovery of human-
created parasite-specific antibodies from archaeological mate-
rials has not been attempted to date. Thus, the preservation 
and degradation of antibodies from an archaeological perspec-
tive have not been fully explored. However, researchers work-
ing with modern samples have reported long-term stability of 
salivary biomolecules [24,25]. Therefore, the potential persis-
tence of parasite-induced human immunoglobulins is concep-
tually plausible. An ideal archaeological potential source mate-
rial for salivary immunoglobulins is the often-ignored quid. 
With the capability to incorporate antibodies from the saliva 
as well as from blood released via microlacerations in the oral 
cavity caused by phytoliths, these artifacts provide a mecha-
nism for assessing archaeological parasitism in a unique way. 
To date, no previous studies have employed ELISA techniques 
for examining quids. The present study represents the first ef-
fort to analyze quids (n=45) for the presence of 2 species of 
protozoan parasites (Toxoplasma gondii and Trypanosoma cruzi).
The quids used in the present study were excavated from La 
Cueva de los Muertos Chiquitos (CMC), a site within the Rio 
Zape Valley, in the early 1960s. This valley lies approximately 
18 km southeast of Guanaceví in Durango, Mexico, and is 
home to a number of caves utilized by the Loma San Gabriel. 
The region illustrates a cultural transition zone between the 
northern most edge of Mesoamerica and the greater American 
Southwest [26-28]. CMC was used year-round as a temporary 
habitation by the Loma San Gabriel between 1,200 and 1,400 
years ago [29,30]. This cave housed an abundance of botanical 
artifacts, the skeletons of 14 children (aged several months to 
5 years at the time of death) as well as some adult bone frag-
ments, nearly 500 coprolites, and over 2,000 quids all sealed 
beneath adobe floors [28,29,31,32]. The people who utilized 
CMC subsisted using a mixed strategy of agricultural produc-
tion and hunting-gathering, both of which fluctuated season-
ally [29,33]. Previous analyses of coprolites reported excellent 
preservation of parasitic helminth eggs [34], bacterial DNA 
[35], and parasite coproantigens [15]. The incredible preserva-
tion of both physical and molecular parasite evidence makes 
this site ideal for testing new methods of parasite evidence re-
covery utilizing quids as source materials.
Previous studies of material from CMC have shown that 
those utilizing the cave had living and nutritional behavior 
patterns that likely perpetuated the life cycles of certain para-
sites [15,33,36]. As these people modified their environments 
to survive, they may have inadvertently promoted the trans-
mission of many different types of parasites, including T. cruzi 
and T. gondii. Evidence of T. cruzi has been recovered from ar-
chaeological materials in North and South America [37-44]. 
The sylvatic cycle of T. cruzi involves a triatomine bug that 
serves as a vector for the parasite and a mammalian definitive 
host. About 180 species of mammals, including bats, carni-
vores, rodents, ungulates, and primates, have been identified 
as reservoir hosts for T. cruzi. Domestic cycles of T. cruzi are 
perpetuated in human populations via vectored transmission 
and via oral transmission of contaminated foods [45]. 
From an archaeological perspective, this parasite is particu-
larly interesting because prehistoric humans of the Southwest-
ern USA and Mesoamerica inserted themselves into the T. cruzi 
life cycle as they changed their environments to better suit 
their survival needs. Reinhard and Araújo [44] discuss the phe-
nomenon of anthropogenic changes to natural habitats that 
led to an increase in vector populations. Simultaneously, hu-
mans induced population decline in reservoir hosts via wood-
rat hunting and habitat displacement, which caused the vec-
tors to come in contact with human hosts more frequently 
than in the past [46]. These behaviors placed humans at risk 
for contracting zoonotic trypanosomiasis that eventually be-
came the American trypanosomiasis (Chagas’ disease) that in-
fects an estimated 10 million people today [47]. The origins of 
T. cruzi can be traced back more than 9,000 years in the New 
World. Analyses of material from mummies place the estab-
lishment of this parasite in the Americas long before European 
contact [39,41,48-50]. Guhl and colleagues [51] explored the 
links between Chagas disease and human migration.
Artifacts from CMC have not previously been tested for evi-
dence of T. cruzi; however, dietary evidence of small rodent 
consumption at this site supports the hypothesis that this par-
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asite may have been cycling among the Loma San Gabriel at 
CMC in prehistory. The majority of evidence regarding T. cruzi 
from archaeological contexts has been collected using molecu-
lar techniques that involve the recovery of DNA [52,53]. One 
study demonstrated that T. cruzi DNA could be recovered from 
experimentally desiccated mouse tissues [54]. To date, ELISA 
techniques have not been applied to archaeological materials 
to recover evidence of T. cruzi. Because commercial ELISA kits 
for T. cruzi are designed to test human serum rather than fecal 
samples, there has not been a practical way of utilizing this 
technique in the search for Chagas’ disease in prehistory. Pin-
ho and colleagues [23] demonstrated that T. cruzi antibodies 
could be recovered from modern saliva using ELISA kits. If 
these antibodies survive following desiccation, there is the po-
tential that ELISA kits could prove to be useful for the recovery 
of T. cruzi evidence from saliva-contaminated artifacts, such as 
the quids excavated from CMC. If the use of ELISA techniques 
in this regard is successful, the archaeoparasitological commu-
nity could enjoy a new rapid, reliable, and cost-effective meth-
od for recovering evidence of T. cruzi from archaeological 
quids.
The origins of toxoplasmosis among humans have been 
more elusive than those of American trypanosomiasis. The ge-
nus Toxoplasma is approximately 10 million years old, with 
Toxoplasma gondii originating sometime in the last 10,000 years 
[55]. Today, about a third of the global human population is 
infected with this parasite [56]. In the United States, this para-
site is responsible for over 300 deaths and 4,000 hospitaliza-
tions annually. In fact, it has been deemed the second most 
important foodborne pathogen in the nation [57]. Within the 
state of Durango, Mexico, modern rural populations have ap-
proximately 35.8% seroprevalence for T. gondii [58]. Alvarado-
Esquivel and colleagues [59] conducted a modern seroepide-
miological study and reported 30.3% seropositivity within a 
Mennonite community in a rural region of Durango, Mexico, 
as compared to 6.1-12% seropositivity in populations residing 
within Durango City, Durango, Mexico.
It is not unreasonable to think that people living near CMC 
may have been infected with T. gondii. Though no clinical cases 
of toxoplasmosis have been reported from bats, there have 
been reports describing the isolation of T. gondii from 2 species 
of bats (Vespertilio pipistrellus and Nyctalus noctula) in the USSR 
[60]. T. gondii is also maintained in a wide variety of wild ani-
mal populations, including rodents, carnivores, and lago-
morphs [61-63]. This means that at least one type of reservoir 
host may have come into contact with people living near 
CMC. Congenital toxoplasmosis within humans may cause 
spontaneous abortions or fetal abnormalities. In modern cases 
of toxoplasmosis among healthy children, symptoms are few 
and most often fleeting. Children with weaken immune sys-
tems who contract toxoplasmosis are at risk for more serious 
neurological symptoms that may cause long-term damage. 
The cause of death among the children buried at CMC is not 
clear, but coprolite analyses show that children using CMC 
were likely malnourished and played hosts to a variety of para-
sites [15,34,35]. The high probability that the people occupy-
ing CMC were exposed to reservoir host species coupled with 
the majority of skeletons from this site being those of children 
make this site an excellent place to look for prehistoric toxo-
plasmosis.
Terra and colleagues [64] demonstrated through experimen-
tal desiccation of infected mice that PCR was effective in the 
recovery of T. gondii DNA; however, to date, there has been no 
archaeological evidence of this parasite recovered from any 
context. As is the case with T. cruzi, ELISA kits have been devel-
oped to test modern human serum for T. gondii antibodies 
rather than for parasite coproantigens in fecal samples. This 
makes such kits inefficient for recovering T. gondii evidence 
from coprolites. Fortunately, Hajeer and colleagues [22] found 
that T. gondii antibodies were detectible in modern saliva using 
ELISA kits developed for testing human serum. As with the 
theory presented for the recovery of T. cruzi evidence utilizing 
CMC quids, we predict that T. gondii evidence could be recov-
ered using ELISA kits to test reconstituted quids. Despite the 
lack of evidence regarding prehistoric, New World toxoplas-
mosis, it is possible that those utilizing CMC may have con-
tracted T. gondii. This parasite is known to infect a wide range 
of endothermic vertebrate hosts, including bats, rodents, and 
carnivores that may have come into contact with the Loma 
San Gabriel who were utilizing CMC. These individuals had 
close relationships with their companion canines, which could 
have been reservoirs for toxoplasmosis, and ate small rodents, 
rabbits, and other potential reservoir hosts that lived in the re-
gion surrounding the cave. Little is known about the paleoepi-
demiology of this parasite. If human antibodies created in re-
sponse to T. gondii 1,300 years ago are capable of surviving 
and being detected using a commercially available ELISA kit, 
archaeoparasitologists would have a new means of tracing the 
origins of human toxoplasmosis in the New World.
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MATERIALS AND METHODS
The 45 CMC quids used for the present study were gathered 
from the collection of over 2,000 quids housed within the 
Pathoecology Laboratory in the School of Natural Resources at 
the University of Nebraska-Lincoln (Fig. 1; Table 1). To pre-
vent modern contamination of material, nitrile gloves were 
worn throughout processing. A total of 45 quids were given a 
laboratory identification number (CMCQ-#) for analysis and 
photographed using a Sony Cybershot 18.2 megapixel camera. 
Each of the quids was analyzed using an Olympus stereoscop-
ic microscope and designated as being comprised of either 
Agave or non-Agave fibers. Other macrofossils, such as cordage 
and charcoal were also noted. 
The quids were rehydrated in their entirety within a plastic, 
conical, 50 ml centrifuge tube containing a 0.5% trisodium 
phosphate solution. Samples were rehydrated for 24 hr before 
rehydration colors were recorded (Table 1). Following rehydra-
tion, the quids were disaggregated using a novel “shake and 
break” method. This method begins with vigorously shaking 
the capped centrifuge tube before vortexing the tube for a few 
seconds. Next, the material within the tube was poured 
through a 250 μm mesh screen over a glass beaker. The tube 
was rinsed with a jet of distilled H2O. Subsequently, sterile for-
ceps were used in conjunction with a sterile spatulette to gently 
break apart the softened quids taking care to free as much of 
the non-fiber matrix of the quids as possible. Another jet of dis-
tilled H2O was applied before removing the fibers/macroscopic 
remains (items larger than 250 μm) on top of the screens to fil-
ter paper for drying. Microscopic remains (those smaller than 
250 μm) were collected back into the centrifuge tubes and cen-
trifuged to create the pellets used for ELISA testing.
Aliquots of processed quid material were assayed for human 
antibodies created in response to T. gondii and T. cruzi infec-
tions using commercially available antibody detection kits. 
ELISA kits were purchased from 2 suppliers: Sigma-Aldrich® 
(St. Louis, Missouri, USA) and Immuno-Biological Laborato-
ries, Inc. [IBL-America] (Minneapolis, Minnesota, USA). The 
Toxoplasma IgA ELISA from Sigma-Aldrich® uses wells coated 
with a purified Toxoplasma antigen to bind with any Toxoplasma 
IgA specific antibodies present within a sample. Unbound ma-
terials are then washed away prior to the addition of an en-
zyme conjugate that binds to existing antibody-antigen com-
plexes when present. An incubation step allows for oxidation 
of the substrate by the enzyme which invokes a color change 
in positive sample wells. The intensity of the color change is 
proportional to the amount of IgA specific antibody present 
within the sample (www.sigma-aldrich.com).
The Chagas (T. cruzi) IgG ELISA from Immuno-Biological 
Laboratories, Inc. [IBL-America] uses microtiter strip wells pre-
Fig. 1. Representative CMC quids (A=CMCQ-37; B=CMCQ-20; C=CMCQ-4; D=CMCQ-21) prior to rehydration. 
A B
C D
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coated with Trypanosoma cruzi antigens to bind human IgG-
class antibodies produced in response to T. cruzi infections. 
Samples are incubated to allow antigen-antibody complexes 
to form before washing procedures remove unbound materi-
als from the sample wells. Next, a horseradish peroxidase 
(HRP) labelled Protein A conjugate is added to bind any anti-
gen-antibody complexes present within the samples. The re-
sultant immune complex that is formed is then visualized fol-
Table 1. Processing data for CMC quids
Sample ID Provenience Level Weight (g) Rehydration color
CMCQ-1 B2 0-6 1.4 dark brown
CMCQ-2 B2 0-6 1.3 black
CMCQ-3 B2 6-12 1.98 black
CMCQ-4 B2 6-12 1 light brown
CMCQ-5 B3 0-4 2.38 black
CMCQ-6 B3 0-4 0.92 dark brown
CMCQ-7 B3 4-8 1.84 light brown
CMCQ-8 B3 4-8 1.96 medium brown
CMCQ-9 B3 8-12 2.43 dark brown
CMCQ-10 B3 16-20 1.6 black
CMCQ-11 B3 16-20 2.05 dark brown
CMCQ-12 B3 20-24 1.8 light brown
CMCQ-13 B3 20-24 1.81 brownish-red
CMCQ-14 B4 4-8 0.88 amber
CMCQ-15 B4 4-8 0.9 black
CMCQ-16 B4 8-12 1.55 dark brown
CMCQ-17 B4 8-12 1.75 light brown
CMCQ-18 B4 12-16 1.4 light brown
CMCQ-19 B4 12-16 1.3 dark brown
CMCQ-20 B4 16-20 2.19 light brown
CMCQ-21 B4 20-24 1.57 amber
CMCQ-22 B4 20-24 1.17 light brown
CMCQ-23 B4 24-28 1.47 amber
CMCQ-24 B4 24-28 1.49 dark brown
CMCQ-25 B4 28-32 0.7 light brown
CMCQ-26 B4 28-32 0.45 amber
CMCQ-27 C1 4-8 1.49 dark brown
CMCQ-28 C1 4-8 1.39 dark brown
CMCQ-29 C1 8-12 2.24 black
CMCQ-30 C1 12-16 0.56 dark brown
CMCQ-31 C2 0-4 2.04 dark brown
CMCQ-32 C2 0-4 1.3 black
CMCQ-33 C2 8-12 2.13 black
CMCQ-34 C2 12-18 0.65 medium brown
CMCQ-35 C2 16-32 1.26 dark brown
CMCQ-36 D1 0-4 0.45 lightbrown
CMCQ-37 D1 4-8 0.58 medium brown
CMCQ-38 D1 8-12 3.02 amber
CMCQ-39 D1 12-16 1.4 light brown
CMCQ-40 D1 16-20 0.58 amber
CMCQ-41 D2 0-12 1.35 medium brown
CMCQ-42 D2 0-12 0.81 brownish-red
CMCQ-43 D2 12-16 2.33 light brown
CMCQ-44 D2 12-16 0.5 light brown
CMCQ-45 D2 16-20 2.51 black
Table 2. Optical density (OD) values and sample designations for 
Toxoplasma gondii testing 
Sample ID OD value #1 OD value #2 Average OD Designation
Calibrator 1.226 1.224 1.23 n/aa
Positive cut-off 1.472 1.345 1.41 n/a
Negative cut-off 0.151 0.166 0.16 n/a
CMCQ-1 0.084 0.118 0.10 negative
CMCQ-2 0.068 0.059 0.06 negative
CMCQ-3 0.074 0.077 0.08 negative
CMCQ-4 0.076 0.072 0.07 negative
CMCQ-5 0.113 0.072 0.09 negative
CMCQ-6 0.06 0.056 0.06 negative
CMCQ-7 0.062 0.062 0.06 negative
CMCQ-8 0.073 0.066 0.07 negative
CMCQ-9 0.069 0.069 0.07 negative
CMCQ-10 0.086 0.089 0.09 negative
CMCQ-11 0.085 0.094 0.09 negative
CMCQ-12 0.083 0.081 0.08 negative
CMCQ-13 0.083 0.07 0.08 negative
CMCQ-14 0.066 0.068 0.07 negative
CMCQ-15 0.073 0.091 0.08 negative
CMCQ-16 0.085 0.093 0.09 negative
CMCQ-17 0.109 0.092 0.10 negative
CMCQ-18 0.076 0.085 0.08 negative
CMCQ-19 0.088 0.078 0.08 negative
CMCQ-20 0.082 0.093 0.09 negative
CMCQ-21 0.083 0.087 0.09 negative
CMCQ-22 0.078 0.074 0.08 negative
CMCQ-23 0.074 0.072 0.07 negative
CMCQ-24 0.081 0.081 0.08 negative
CMCQ-25 0.081 0.073 0.08 negative
CMCQ-26 0.071 0.071 0.07 negative
CMCQ-27 0.076 0.078 0.08 negative
CMCQ-28 0.082 0.077 0.08 negative
CMCQ-29 0.084 0.107 0.10 negative
CMCQ-30 0.063 0.078 0.07 negative
CMCQ-31 0.068 0.068 0.07 negative
CMCQ-32 0.066 0.071 0.07 negative
CMCQ-33 0.063 0.068 0.07 negative
CMCQ-34 0.064 0.072 0.07 negative
CMCQ-35 0.076 0.084 0.08 negative
CMCQ-36 0.076 0.075 0.08 negative
CMCQ-37 0.076 0.072 0.07 negative
CMCQ-38 0.062 0.065 0.06 negative
CMCQ-39 0.069 0.071 0.07 negative
CMCQ-40 0.082 0.085 0.08 negative
CMCQ-41 0.072 0.076 0.07 negative
CMCQ-42 0.071 0.074 0.07 negative
CMCQ-43 0.079 0.078 0.08 negative
CMCQ-44 0.075 0.076 0.08 negative
CMCQ-45 0.075 0.072 0.07 negative
aNot applicable.
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lowing the addition of tetramethylbenzidine (TMB) substrate. 
The intensity of the color change is proportional to the amount 
of T. cruzi-specific IgG antibodies present within the samples. 
This kit has a specificity of 99% and a sensitivity of 99% (www.
ibl-america.com).
Quid samples were subjected to ELISA testing for T. gondii 
and T. cruzi evidence at the Zera Lab within the School of Bio-
logical Sciences at the University of Nebraska-Lincoln. Samples 
were tested in duplicate along with controls provided by the 
manufacturers following manufacturer instructions. A visual 
inspection was conducted following the addition of each kit’s 
stop solution and optical density (OD) values were collected 
with the aid of an Omega ELISA plate reader (Tables 2, 3). 
The OD readings were used to determine the presence or 
absence of each parasite using the interpretational procedures 
outlined for each kit by the manufacturers (Tables 2, 3). For 
the Toxoplasma IgA ELISA, the kit-specific Calibration Factor 
was multiplied by the OD value for the calibrator provided 
(must be greater than 0.250 to be considered valid) to deter-
mine the cut-off value. The Ab (antibody) Index was then cal-
culated by dividing the OD value of the provided positive con-
trol by the cut-off value. The Ab Index was similarly calculated 
for the provided negative control and for each quid sample. 
Samples with an Ab Index less than 0.9 were designated as be-
ing negative while samples with an Ab Index greater than 1.2 
Table 3. Optical density (OD) values and sample designations for 
Trypanosoma cruzi testing 
Sample ID OD Value #1 OD Value #2 Average OD Designation
Substrate blank 0.031 0.045 0.04 n/aa
Negative control 0.106 0.14 0.12 n/a
Positive control 2.294 2.475 2.38 n/a
Cut-off control 0.719 0.719 0.72 n/a
CMCQ-1 0.034 0.032 0.03 negative
CMCQ-2 0.103 0.029 0.07 negative
CMCQ-3 0.03 0.06 0.05 negative
CMCQ-4 0.035 0.035 0.04 negative
CMCQ-5 0.03 0.03 0.03 negative
CMCQ-6 0.037 0.045 0.04 negative
CMCQ-7 0.039 0.041 0.04 negative
CMCQ-8 0.041 0.043 0.04 negative
CMCQ-9 0.052 0.035 0.04 negative
CMCQ-10 0.035 0.035 0.04 negative
CMCQ-11 0.039 0.04 0.04 negative
CMCQ-12 0.043 0.041 0.04 negative
CMCQ-13 0.044 0.034 0.04 negative
CMCQ-14 0.037 0.029 0.03 negative
CMCQ-15 0.043 0.041 0.04 negative
CMCQ-16 0.046 0.059 0.05 negative
CMCQ-17 0.101 0.034 0.07 negative
CMCQ-18 0.126 0.035 0.08 negative
CMCQ-19 0.044 0.033 0.04 negative
CMCQ-20 0.051 0.091 0.07 negative
CMCQ-21 0.051 0.038 0.04 negative
CMCQ-22 0.036 0.034 0.04 negative
CMCQ-23 0.029 0.074 0.05 negative
CMCQ-24 0.036 0.041 0.04 negative
CMCQ-25 0.043 0.038 0.04 negative
CMCQ-26 0.028 0.032 0.03 negative
CMCQ-27 0.035 0.043 0.04 negative
CMCQ-28 0.041 0.044 0.04 negative
CMCQ-29 0.04 0.039 0.04 negative
CMCQ-30 0.04 0.056 0.05 negative
CMCQ-31 0.037 0.038 0.04 negative
CMCQ-32 0.037 0.049 0.04 negative
CMCQ-33 0.053 0.036 0.04 negative
CMCQ-34 0.036 0.034 0.04 negative
CMCQ-35 0.038 0.037 0.04 negative
CMCQ-36 0.127 0.047 0.09 negative
CMCQ-37 0.036 0.036 0.04 negative
CMCQ-38 0.039 0.034 0.04 negative
CMCQ-39 0.04 0.041 0.04 negative
CMCQ-40 0.047 0.086 0.07 negative
CMCQ-41 0.058 0.056 0.06 negative
CMCQ-42 0.04 0.035 0.04 negative
CMCQ-43 0.036 0.043 0.04 negative
aNot applicable.
Table 4. Processing data for quids utilized in secretory IgA (sIgA) 
testing 
Sample ID Provenience Level Weight (g) Rehydration color
CMCQ-3 B2 6-12 1.98 black
CMCQ-5 B3 0-4 2.38 black
CMCQ-13 B3 20-24 1.81 brownish-red
CMCQ-16 B4 8-12 1.55 dark brown
CMCQ-21 B4 20-24 1.57 amber
CMCQ-24 B4 24-28 1.49 dark brown
CMCQ-29 C1 8-12 2.24 black
CMCQ-35 C2 16-32 1.26 dark brown
CMCQ-37 D1 4-8 0.58 medium brown
CMCQ-39 D1 12-16 1.4 light brown
CMCQ-43 D2 12-16 2.33 light brown
CMCQ-46 B2 0-6 0.53 black
CMCQ-47 B2 6-12 0.46 light brown
CMCQ-48 B3 4-8 0.59 light brown
CMCQ-49 B3 12-16 0.76 medium brown
CMCQ-50 B3 16-20 1.05 amber; opaque
CMCQ-51 B3 20-24 1.13 light brown
CMCQ-52 B4 16-20 1.71 amber
CMCQ-53 B4 24-28 0.87 yellow-gray
CMCQ-54 C2 0-4 0.71 black
CMCQ-55 D2 0-12 0.37 light brown
CMCQ-56 D2 12-16 0.15 light brown
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were deemed to be considered positive. Samples with Ab Indi-
ces between 0.9 and 1.2 were considered borderline positive 
and would require follow-up testing for validation (Table 2). 
The cut-off value for the Chagas (T. cruzi) IgG ELISA was cal-
culated by taking the average of the OD values for the cut-off 
control wells. Substrate blank-corrected sample OD values less 
than the cut-off were considered negative, while values greater 
than the cut-off were considered positive. For the assay to be 
considered valid, cut-off values had to range between 0.150 
and 1.30 prior to blank correction (Table 3).
Following these analyses, it became apparent that further 
method development would be necessary to validate interpre-
tations. To facilitate this, sIgA ELISA test kit from Eagle Biosci-
ences, Inc. was utilized. A total of 11 CMC quids processed for 
the tests described above were chosen to represent many dif-
ferent proveniences and depths (CMCQ#s: 3, 5, 13, 16, 24, 29, 
35, 37, 39, and 43). Additionally, 11 previously unprocessed 
quids were selected from the CMC collection held within the 
Pathoecology Laboratory at UNL’s School of Natural Resourc-
es. These quids were weighed, photographed, rehydrated in 
0.5% trisodium phosphate, and further processed as previous-
ly described (Table 4). 
Aliquots from each of these 22 samples were transferred into 
pre-labeled microcentrifuge tubes. A second aliquot of precisely 
10 μl from each sample was placed into microcentrifuge tubes 
along with 990 μl of wash buffer to test whether or not dilu-
tion of samples made a difference in the recovery of antibodies 
using these techniques. All samples were run in duplicate for 
both their diluted and undiluted varieties (Tables 5-7).
The sIgA ELISA from Eagle Biosciences, Inc. uses a pre-coat-
ed microtiter plate to bind sIgA within samples, standards, and 
controls. After an initial wash, a peroxidase-labeled detection 
Table 5. Optical density (OD) values for sIgA testing of undiluted 
quid samples 
Sample ID OD value #1 OD value #2 Average OD Designation
Control 1 0.272 n/aa n/a n/a
Control 2 0.852 n/a n/a n/a
Standard 0 0.064 n/a n/a n/a
Standard 22.2 0.209 n/a n/a n/a
Standard 66.6 0.256 n/a n/a n/a
Standard 200 0.54 n/a n/a n/a
Standard 600 1.157 n/a n/a n/a
0.5 % TSP 0.161 n/a n/a n/a
CMCQ-3 0.081 0.05 0.0655 negative
CMCQ-5 0.06 0.055 0.0575 negative
CMCQ-13 0.068 0.06 0.064 negative
CMCQ-16 0.054 0.191 0.1225 negative
CMCQ-21 0.135 0.059 0.097 negative
CMCQ-24 0.101 0.073 0.087 negative
CMCQ-29 0.104 0.076 0.09 negative
CMCQ-35 0.067 0.063 0.065 negative
CMCQ-37 0.051 0.076 0.0635 negative
CMCQ-39 0.055 0.061 0.058 negative
CMCQ-43 0.053 0.102 0.0775 negative
CMCQ-46 0.064 0.066 0.065 negative
CMCQ-47 0.057 0.057 0.057 negative
CMCQ-48 0.135 0.07 0.1025 negative
CMCQ-49 0.059 0.121 0.09 negative
CMCQ-50 0.043 0.066 0.0545 negative
CMCQ-51 0.087 0.113 0.1 negative
CMCQ-52 0.1 0.059 0.0795 negative
CMCQ-53 0.059 0.065 0.062 negative
CMCQ-54 0.056 0.112 0.084 negative
CMCQ-55 0.083 0.065 0.074 negative
CMCQ-56 0.109 0.099 0.104 negative
aNot applicable.
Table 6. Optical density (OD) values for sIgA testing of diluted 
quid samples 
Sample ID OD value #1 OD value #2 Average OD Designation
Control 1 0.272 n/aa n/a n/a
Control 2 0.852 n/a n/a n/a
Standard 0 0.064 n/a n/a n/a
Standard 22.2 0.209 n/a n/a n/a
Standard 66.6 0.256 n/a n/a n/a
Standard 200 0.54 n/a n/a n/a
Standard 600 1.157 n/a n/a n/a
0.5 % TSP 0.161 n/a n/a n/a
CMCQ-3 0.123 0.113 0.118 negative
CMCQ-5 0.06 0.055 0.0575 negative
CMCQ-13 0.051 0.157 0.104 negative
CMCQ-16 0.083 0.132 0.1075 negative
CMCQ-21 0.066 0.097 0.0815 negative
CMCQ-24 0.079 0.127 0.103 negative
CMCQ-29 0.123 0.057 0.09 negative
CMCQ-35 0.083 0.238 0.1605 negative
CMCQ-37 0.111 0.128 0.1195 negative
CMCQ-39 0.082 0.096 0.089 negative
CMCQ-43 0.067 0.085 0.076 negative
CMCQ-46 0.108 0.111 0.1095 negative
CMCQ-47 0.095 0.072 0.0835 negative
CMCQ-48 0.062 0.057 0.0595 negative
CMCQ-49 0.134 0.064 0.099 negative
CMCQ-50 0.055 0.034 0.0445 negative
CMCQ-51 0.103 0.039 0.071 negative
CMCQ-52 0.09 0.046 0.068 negative
CMCQ-53 0.06 0.038 0.049 negative
CMCQ-54 0.185 0.084 0.1345 negative
CMCQ-55 0.061 0.043 0.052 negative
CMCQ-56 0.07 0.073 0.0715 negative
aNot applicable.
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antibody is added, which binds to the antibody complex. A 
second wash is performed before adding a substrate, which is 
converted by the peroxidase to result in a colored product. The 
addition of an acidic stop solution terminates this reaction and 
optical densities are read at 450 nm. The optical densities are 
then used to calculate sIgA concentrations with the help of a 
standard curve (www.eaglebio.com). For the purposes of this 
study, sIgA concentrations were not calculated as a simple pres-
ence/absence test was all that was needed to test the methods.
RESULTS
Visual inspection of the ELISA plates was conducted prior to 
the collection of OD values via the ELISA plate reader. Posi-
tive/negative assessments were recorded on the basis of a visu-
al color change and later compared to sample designations us-
ing OD values. All sample wells across both test kits were con-
sidered negative via visual inspection.
Data collected via the ELISA plate reader also yielded nega-
tive results for both test kits. The OD values from these analy-
ses were recorded and samples were designated positive/nega-
tive according to cut-off value calculations using manufactur-
ers’ interpretational protocols (Tables 2, 3).
Visual inspection designations were in 100% agreement 
with sample designations determined using OD values. All 
controls used in both kits yielded OD values within acceptable 
ranges for considering the kits valid according to manufactur-
ers’ specifications.
A visual inspection of the sIgA ELISA wells produced 2 posi-
tive test wells from CMCQ-35 and CMCQ-49 (both diluted). 
However, the duplicates of both wells were visually negative. 
Upon examination of OD values, only CMCQ-35 remained 
positive, again with its duplicate well being negative. Because 
duplicate wells for both samples were not consistently positive 
and because average OD values led to negative designations 
for both samples, these were considered anomalies rather than 
true positive results.
Because the sIgA ELISA kit used was developed for determin-
ing concentration levels of sIgA in modern samples and not for 
determining presence/absence of sIgA in archaeological sam-
ples, positive/negative determinations were reached as follows. 
The OD value for 0.5% trisodium phosphate (0.161) was sub-
tracted from each sample OD value (i.e. the OD value for the 
rehydration solution was used as a blank). Blank-corrected OD 
values were then compared to the OD values acquired for the 
kit-provided standards. None of the OD values were close to 
the higher ng/μl standards (i.e. the 200 ng/μl standard and the 
600 ng/μl standard), so OD values were instead compared to 
the OD values for the 22.2 ng/μl standard and the 0 ng/μl stan-
dard. Blank-corrected OD values greater than the OD value for 
the 0 ng/μl standard (0.064) were considered potentially posi-
tive. Average OD values calculated rom sample duplicates were 
also compared to the OD value for the 0 ng/μl standard 
(0.064) and the entire quid was considered potentially positive 
if greater than 0.064. Similar comparisons were made using the 
OD values for the 22.2 ng/μl standard (0.209). Samples with 
OD values and OD value averages greater than 0.209 were con-
sidered positive for trace amounts of sIgA. Only a single test 
well (CMCQ-35--diluted) was deemed potentially positive in 
this way. However, since the duplicate for this well was negative 
and the average OD value for this quid yielded a negative des-
ignation, this was not found to be significant and was likely a 
false positive as a result of an error in processing. All other 
sample wells were found to be negative when compared to OD 
readings for the standards.
The average OD values for each sample in their diluted and 
undiluted forms were compared. Out of the 22 samples tested, 
Table 7. Optical density (OD) values for sIgA testing of undiluted 
quid samples 
Sample ID
Undiluted samples
(average OD)
Diluted samples
(average OD)
Higher OD
CMCQ-3 0.0655 0.118 diluted
CMCQ-5 0.0575 0.0575 same
CMCQ-13 0.064 0.104 diluted
CMCQ-16 0.1225 0.1075 undiluted
CMCQ-21 0.097 0.0815 undiluted
CMCQ-24 0.087 0.103 diluted
CMCQ-29 0.09 0.09 same
CMCQ-35 0.065 0.1605 diluted
CMCQ-37 0.0635 0.1195 diluted
CMCQ-39 0.058 0.089 diluted
CMCQ-43 0.0775 0.076 undiluted
CMCQ-46 0.065 0.1095 diluted
CMCQ-47 0.057 0.0835 diluted
CMCQ-48 0.1025 0.0595 undiluted
CMCQ-49 0.09 0.099 same
CMCQ-50 0.0545 0.0445 undiluted
CMCQ-51 0.1 0.071 undiluted
CMCQ-52 0.0795 0.068 undiluted
CMCQ-53 0.062 0.049 undiluted
CMCQ-54 0.084 0.1345 diluted
CMCQ-55 0.074 0.052 undiluted
CMCQ-56 0.104 0.0715 undiluted
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3 produced the same OD value whether or not they were di-
luted. A total of 9 samples yielded higher OD values for dilut-
ed samples while a total of 10 samples yielded higher OD val-
ues for undiluted samples (Table 7). 
DISCUSSION
While other studies have successfully employed ELISA tech-
niques for recovering parasite evidence from latrine and burial 
sediments [3,4,10] as well as coprolites [2,14,15], none have 
successfully recovered parasite antigens or parasite-induced 
antibodies from quids. Although the present study was not 
successful in the recovery of parasite-induced antibodies from 
CMC quids, the study represents the first attempt to use quids 
as a source material for archaeoparasitological investigations. 
There are several reasons why this study’s attempt at the re-
covery of parasite evidence from quids may have failed. De-
spite the recovery of T. gondii and T. cruzi antibodies from 
modern saliva, it is important to note that ELISA kits available 
for T. gondii and T. cruzi are marketed for use with human se-
rum. Furthermore, these kits are marketed for modern materi-
al and not for reconstituted archaeological material, which 
could compromise the abilities of the kits to actually detect 
ancient antibodies. This has not been a problem for the recov-
ery of parasite coproantigens out of archaeological materials, 
but antibodies may degrade differently than do coproantigens. 
The negative results of the subsequent sIgA ELISA tests support 
this. Antibodies are much more structurally complex and 
heavier than antigens. These molecules weigh about 150 kDa 
as compared to the average antigen weighing in at around 14 
kDa. The smaller size and relative structural simplicity of anti-
gens make them less likely to degrade in ways that would ren-
der ELISA testing inefficient. It is unknown whether or not 
plant products, such as those made by Agave and other types 
of botanicals found in quids, have an adverse effect on the 
preservation of antibodies and antigens. If so, such products 
could also contribute to antibody degradation, which further 
complicates the ELISA testing of quids. The archaeological 
context, structural components of antibodies/antigens, anthro-
pogenic behaviors regarding quid chewing, and ecological in-
teractions of plants with target antibodies/antigens may all 
contribute to the taphonomy of immunological parasite evi-
dence in much the same way that similar factors contribute to 
the degradation of physical parasite eggs within archaeological 
contexts as described by Morrow and colleagues [65]. Even so, 
the taphonomic impacts of archaeological antibody/antigen 
recovery have not been thoroughly assessed at the present 
time. Future examinations of antibody degradation resulting 
from desiccation could elucidate the nature of human anti-
body taphonomy and its implications on archaeoparasitologi-
cal recovery techniques.
Alternatively, the capabilities of the ELISA test kits utilized in 
the present study could be sound for the recovery of archaeo-
logical antibodies given the proper quid processing methods. 
Without precedent in the existing literature, quid processing 
methods were developed by modifying coprolite processing 
techniques deemed successful for the recovery of parasite 
coproantigens [15]. Further refinement of quid processing 
methods could provide avenues for the successful recovery of 
parasite evidence utilizing ELISA kits.
Finally, the results of these analyses could have been nega-
tive simply because the individuals who created the CMC 
quids were not infected with T. gondii or T. cruzi. The pathoeco-
logical potential of parasitism does not always reflect true par-
asitism within a given population. The individuals utilizing 
CMC could have circumvented entry into zoonotic cycles of 
these parasites by avoiding transmission pathways. Transmis-
sion pathway avoidance could have been a result of cultural 
behaviors that limited infection risks. The coprolites of these 
individuals contained large quantities of dietary fiber [18,20], 
which may reflect a greater reliance on plant foodstuffs than 
on wild game. Although these people were known to ingest 
rodents, perhaps the animals they were consuming were not 
serving as reservoir hosts for either of these parasites around 
CMC at that time.
Despite the lack of positive results, the employment of ELI-
SA for the recovery of parasite evidence using quids as source 
materials remains a plausible concept. Future ELISA tests of 
quids should target parasite antigens as opposed to parasite-
induced human antibodies, though currently, few such tests 
have been developed for samples of non-fecal origin. Future 
researchers should approach this concept by modifying pro-
cessing methods, experimenting with different epitope targets 
and brands of ELISA kits, and performing methodological ex-
periments using artificially-created quids known to contain 
target antibodies. Such experimentation could provide the 
foundational data needed to develop reliable techniques for 
recovering parasite evidence from quids.
The development of successful methods for the archaeopar-
asitological analysis of quids would open new venues of re-
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search regarding ancient parasitism. Potentially, parasites that 
do not leave behind traceable coproantigens, such as T. gondii 
and T. cruzi, could be detected via residual salivary products 
present in artifacts like quids. As researchers move forward 
with the analysis of quids, it is important to consider the limi-
tations of ELISA testing. Such limitations include taphonomic 
degradation of target antibodies/antigens within quids, cross-
reactivity potential with other parasites, and the presence of 
bacteria or fungi that may compromise test validity. To address 
these limitations, processing methods should be designed to 
inflict little damage to potential antibodies/antigens, only kits 
that are highly specific/sensitive should be employed, and 
samples should be tested quickly after being reconstituted be-
fore bacterial and fungi are able to colonize samples. It is also 
vital that future researchers acknowledge that archaeoparasito-
logical data do not reflect actual infection rates in past popula-
tions with 100% accuracy. Nonetheless, immunological testing 
of archaeological samples provides valuable tools for estimat-
ing the parasite burdens among peoples of the past. Our abili-
ty to more accurately assess protozoan parasitism of the past 
has improved with the progression of technology and will 
continue to be refined as new archaeoparasitological immu-
nodiagnostic techniques become available.
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